Sarcopenia – A Potential Target for Angiotensin-Converting Enzyme Inhibition?

Publisher： Karger

E-ISSN： 1423-0003|52|4|237-242

ISSN： 0304-324x

Source： Gerontology, Vol.52, Iss.4, 2006-07, pp. : 237-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Renin-Angiotensin-Aldosterone System: Approaches to Guide Angiotensin-Converting Enzyme Inhibition in Patients with Coronary Artery Disease

By  

Cardiology, Vol. 112, Iss. 4, 2008-10 ,pp. : 303-312

Karger

Access to resources Recommend Favorite

Arteriovenous Fistula Patency Associated with Angiotensin-Converting Enzyme I/D Polymorphism and ACE Inhibition or AT1 Receptor Blockade

By  

Nephron Clin Pract, Vol. 111, Iss. 2, 2009-01 ,pp. : c110-c116

Karger

Access to resources Recommend Favorite

Changes in Vascular Distensibility during Angiotensin-Converting Enzyme Inhibition Involve Bradykinin Type 2 Receptors

By  

Journal of Vascular Research, Vol. 41, Iss. 1, 2004-02 ,pp. : 18-27

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors and Smoking Cessation

By  

Respiration, Vol. 74, Iss. 4, 2007-05 ,pp. : 478-478

Karger

Access to resources Recommend Favorite

INFLUENCE OF CONVERTING ENZYME INHIBITION ON THE RELEASE OF VASOPRESSIN INDUCED BY ANGIOTENSIN

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 71, Iss. 1, 1980-01 ,pp. : 337-341

John Wiley & Sons Inc

Access to resources Recommend Favorite